Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation

por Ludwig, Lindsey M., Nassin, Michele L., Hadji, Abbas, LaBelle, James L.
Publicado 2016

The addition of autologous stem cell transplantation to neoadjuvant chemotherapy, radiation, and HIPEC for patients with unresectable desmoplastic small round cell tumor: a single...

por Siddiqui, Amir, Pinto, Navin, Applebaum, Mark A., Mak, Grace Z., Cunningham, John M., LaBelle, James L., Nassin, Michele L.
Publicado 2020

PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS

por Abboud, Miguel, Kanter, Julie, Marfo, Kwaku, Anthony, Charmaine, Lincy, Jeremie, Nassin, Michele, Joshi, Vikas, Brueckner, Andreas, Keefe, Deborah, Ataga, Kenneth I.
Publicado 2023

S267: PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND EFFICACY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE AGED 12 TO <18 YEARS: 2-YEAR DATA FROM THE PHASE 2 SOLACE-KIDS ST...

por Heeney1, Matthew, Rees, David, de Montalembert, Mariane, Odame, Isaac, Wali, Yasser, Sayyed, Sarfaraz, Shanmuganathan Muthusamy, Velusamy, Mendonza, Anisha E., Nassin, Michele, Keefe, Deborah, Kanter, Julie
Publicado 2023